Objective: Endovascular treatment of thoracoabdominal aortic aneurysms (TAAAs) with branched and fenestrated stent grafts often requires upper extremity arterial access for antegrade delivery of bridging covered stents into the visceral arteries. Axillary, brachial, and radial artery approaches have been described, but data on the safety and utility of the different approaches remain limited. We have preferentially used axillary artery conduits for upper extremity arterial access during endovascular repair of TAAA and describe our technique and report our experience herein.
Contemporary morbidity and mortality rates for open surgical repair of thoracoabdominal aortic aneurysms (TAAAs) remain high, even at the highest volume centers. 1 National data suggest a perioperative mortality of at least 10%, with morbidity occurring in >50% overall. 2, 3 Consequently, there is growing interest in endovascular treatment of TAAA with fenestrated and branched graft technology. Since the first report of implantation into a patient with a contained supraceliac rupture, 4 several centers have reported outcomes for endovascular repair of TAAA with encouraging early results that are comparable to those of open surgical repair at highvolume centers, even in patients who are at high risk for open surgery. [5] [6] [7] [8] Upper extremity access is often required during complex endovascular aortic surgery, as is the case with endovascular TAAA repair to deliver bridging stent components through antegrade-directed branches and to deliver parallel visceral stents during chimney and sandwich procedures. The left side may be preferable to limit passage of devices through the aortic arch. A variety of approaches and techniques have been described for upper extremity arterial access, including radial, brachial (both percutaneous and open), and axillary; however, there is no consensus on the best approach. [9] [10] [11] We have preferentially used an axillary artery approach with a temporary conduit to facilitate delivery of bridging components during endovascular repair of TAAA with branched and fenestrated stent grafts. We have found that axillary conduits are well tolerated and have several advantages over alternative approaches, including being The editors and reviewers of this article have no relevant financial relationships to disclose per the JVS policy that requires reviewers to decline review of any manuscript for which they may have a conflict of interest.
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http://dx.doi.org/10.1016/j.jvs.2016.12.107 able to deliver large sheaths without interruption of upper extremity perfusion, shortening the working distance to the visceral arteries, and permitting full angulation of the C arm because the arms remain tucked at the patient's side. Herein we describe our experience and outcomes with use of axillary conduits for delivery of bridging stent graft components during endovascular treatment of TAAA.
METHODS
As part of an investigator-sponsored investigational device exemption clinical trial (G130193) between 2014 and 2016, there were 32 patients with TAAAs deemed at high risk for open surgical repair treated with custom branched or fenestrated stent grafts (Cook, Inc, Bloomington, Ind). The protocol and informed consent were approved by the Institutional Review Board, and all patients gave informed consent. Bilateral femoral artery access for delivery of aortic stent graft components was obtained either percutaneously with Perclose ProGlide (Abbott Vascular, Santa Clara, Calif) closure or surgical cutdown based on the patient anatomy's and the attending physician's preference. Bridging visceral stent graft components were preferentially delivered through the left axillary artery, using a temporary conduit.
The axillary artery was exposed through a transverse infraclavicular incision. After anticoagulation with intravenous heparin, a 6-mm-diameter Dacron graft (Hemashield; Maquet, Wayne, NJ) was sewn end to side to the axillary artery by a running 5-0 polypropylene suture (Fig 1) . The conduit was then tunneled subcutaneously and brought out through a small counterincision located a few centimeters inferolaterally for better ergonomics (Fig 2) . The axillary conduit was accessed with a 5F sheath; a guidewire was advanced into the descending thoracic aorta and was snared from a femoral approach to establish axillary-femoral through-wire access. The axillary sheath was subsequently exchanged for a 12F High-Flex Ansel sheath (Cook, Inc), which was advanced over the through-wire into the descending thoracic aorta. The through-wire was maintained to stabilize the sheath, and additional sheaths and guidewires for delivery of bridging covered stent components into target visceral arteries were introduced through the 12F sheath alongside the through-wire. After the endovascular TAAA repair was completed, the sheaths were removed and the axillary conduit was transected, leaving a 3-to 4-mm cuff of graft material attached to the artery. The graft cuff was closed by oversewing it with running 5-0 polypropylene suture in two layers, creating a functional patch closure to prevent narrowing of the artery. The incision was then closed with absorbable sutures.
RESULTS
Baseline characteristics of the patients treated are outlined in Table I . The average age of the study patients was 75.6 6 8.3 years, with an average maximal aneurysm diameter of 69.6 6 10.6 mm; 81.2% of patients were male, 71.8% white, 18.7% African American, 6.2% Latino, and 3.1% Asian. All patients were American Society of Anesthesiologists class 3 (68.8%) or class 4 (31.2%). Anatomically, thoracoabdominal aneurysms by Crawford classification included 1 extent I (3.1%), 3 extent II (9.3%), 10 extent III (31.2%), and 15 extent IV (46.9%). Three patients (9.3%) had pararenal aneurysms; 15.6% of patients had a prior endovascular aortic aneurysm repair, and 40.6% had a prior open surgical aortic repair. Many patients had multiple medical comorbidities; comorbid conditions are summarized in Table II. A total of 208 components were used in 81 branches and 41 fenestrations, corresponding to 122 target visceral arteries. Of the fenestrations, 27 of 41 (65.8%) were cannulated through an upper extremity approach and the remainder through a femoral approach. All branches were cannulated through an upper extremity approach. Axillary conduits were used for upper extremity access in 29 of the 31 patients (93.5%), and a total of 170 components were delivered into 108 target arteries through axillary conduits (average of 5.9 components per patient); the individual breakdown of bare-metal and covered stents deployed is summarized in Table III . Twentyseven of 29 (93.1%) axillary conduits were left-sided, and two right-sided conduits were used in patients with permanent pacemakers overlying the left axillary artery.
Technical success was achieved in 107 of 108 cases (99.1%), defined as cannulation of the branch or fenestration and target vessel with successful deployment of bridging components and patency on completion angiography. In one patient, an accessory renal artery could not be cannulated through an antegrade branch, and the branch was sacrificed.
There were two postoperative complications possibly related to the axillary conduits. One patient experienced arm weakness, probably from a brachial plexopathy on the ipsilateral side. Another patient suffered a minor ipsilateral stroke, presumably in the anterior circulation with symptoms of arm weakness on the contralateral side. However, a computed tomography scan of the brain did not reveal an infarct or hemorrhage, and the diagnosis of a presumed stroke was based on clinical presentation. His symptoms had resolved by the first postoperative visit at 1 month. There were no instances of arm ischemia or wound hematoma, and no reoperations related to the axillary conduits were required. No late complications related to the conduits have been observed in follow-up out to 2 years (mean, 226 6 225 days; range, 6-794 days).
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DISCUSSION
On the basis of our experience, the axillary conduit technique provides excellent access for introduction of stent graft components during complex aortic endovascular procedures. There were no intraoperative complications related to the conduit, and postoperative complications were infrequent, occurring in just 2 of 29 (6.9%) patients. These results compare favorably with other upper extremity access techniques and are also consistent with results reported for use of axillary conduits during complex aortic procedures with parallel (snorkel/chimney) grafts. 11 Axillary conduits maintain perfusion to the arm while a large 12F sheath remains in place. There were no thrombotic or embolic events noted to the ipsilateral hand or fingers, and the one complication of transient hand weakness was likely to be related to brachial plexus injury during axillary artery exposure. The one likely embolic neurologic event was a minor ipsilateral stroke in the anterior territory and may have been related to access through the aortic arch either from the axillary conduit or from passage of wires from the femoral arteries. There were no lasting neurologic sequelae in this patient. In retrospect, there was not a significant thrombus burden in the aortic arch or any aberrant anatomy that could have predicted this event. There were no hematomas, no need for reoperation, and no late complications attributed to the axillary artery conduit, further underscoring the safety of the technique. The most commonly used technique for upper extremity access during complex endovascular aortic procedures has been either percutaneous or open access to the brachial artery. 9 Although reasonably safe, with percutaneous access there is risk of brachial sheath hematoma, which can cause median nerve compression and neurologic deficits 12, 13 as well as vessel injury and pseudoaneurysm formation, thrombosis, and dissection. 14 Open brachial exposure appears to mitigate many of these complications, 10 but large sheaths may be occlusive within the brachial artery, leaving patients at risk for complications related to extremity ischemia.
Anecdotally, we converted from open brachial artery access to our current approach using axillary conduits after several patients with brachial access suffered postoperative hand numbness and paresthesias thought to be related to ischemia from prolonged occlusion of the brachial artery by 12F sheaths. Safety data regarding the use of axillary conduits for access during complex endovascular procedures are limited, although Wooster et al recently reported their experience during aortic stent grafting with parallel stents delivered by either open brachial or axillary artery conduit access. 11 In their series, brachial artery access was associated with more complications than axillary conduits were and included 1 hematoma, 1 median nerve injury, and 2 brachial artery injuries requiring intraoperative repair with interposition bypass using greater saphenous vein of 23 cases. Twenty-seven axillary artery conduits were used, and there were three hematomas (two of which required surgical intervention) but no neurologic, vascular, or ischemic complications. The authors stated their preference for use of axillary conduit access when multiple sheaths or a single sheath larger than 8F is necessary. Use of the axillary artery offers several theoretical benefits over the brachial artery in this context; the axillary artery more easily accommodates the larger sheath sizes needed for aortic interventions, there is no concern for brachial sheath hematoma, and the working distance to the visceral aortic segment is decreased. Use of the axillary artery permits the arms to be tucked at the patient's side throughout the procedure, which facilitates rotation of the C arm around the patient during the procedure. With use of a conduit, perfusion can be maintained to the distal extremity throughout the procedure. Although we uniformly delivered only 12F sheaths through 6-mm Dacron conduits, larger conduits can be used to allow introduction of larger or multiple sheaths. For delivery of the branch components, we generally pass a flexible sheath through the 12F sheath into the target branches one at a time. Sheath lengths of 70 cm are generally adequate to reach the target vessels from the axillary approach. Up to a 9F sheath can easily be accommodated alongside a 0.014-inch through-wire within the 12F sheath. The 12F sheath can also accommodate up to three additional 0.018-inch guidewires alongside a 6F sheath. We generally perform sequential cannulation of the visceral branches, but if multiple branches are simultaneously cannulated, a larger anchoring sheath may be required. We did not find 12F sheaths to be occlusive in the axillary artery, but if a larger sheath does occlude flow, the use of the conduit allows the sheath to be periodically withdrawn out of the artery to restore extremity perfusion while guidewire access is maintained. Use of the conduit also offers several benefits compared with direct arterial puncture. The conduit may protect the artery from damage during sheath exchanges and provide more control if the artery is located deep to the skin. There may also be less blood loss with this method, although we have not formally compared conduits with direct puncture strategies. By tunneling the conduit subcutaneously to a small, inferolateral counterincision, the conduit is positioned so that it is easily accessible through the procedure and eliminates severe angulation that may exist when the conduit is brought out through the same incision, as is the case with direct puncture. Oversewing the small cuff of graft material left on the artery as a patch is straightforward and prevents narrowing of the vessel at the access site.
Axillary artery conduits do have several limitations, and selection of the patient is of paramount importance. Presence of an overlying permanent pacemaker, tunneled catheter, or subcutaneous port can obstruct exposure of the axillary artery, but in these cases, use of the contralateral side is often possible. Patients with left internal mammary artery to left anterior descending coronary artery bypasses should also undergo right-sided access as the presence of the sheath may lead to myocardial ischemia. In obese or barrel-chested patients, the artery may be deep and more difficult to expose. Prior axillary artery exposure and irradiation may add additional technical difficulties and risks and should be considered relative contraindications. With regard to anatomic issues, all patients have preoperative imaging of the arch and its branches, and we use the axillary conduit technique in virtually all types of aortic anatomy.
In this series, several patients with steeply angled and tortuous arches were successfully treated as the through-wire facilitates passage of the 12F sheath into the descending aorta even in these cases. Thrombusladen arches pose an increased risk of embolic events, presenting a relative contraindication to axillary access. Finally, compared with brachial artery exposure, axillary artery exposure does take longer, but we believe the added benefits and safety profile associated with the axillary conduit approach more than justify the added procedural time.
CONCLUSIONS
This study highlights the safety and utility of the axillary conduits for upper extremity access during endovascular repair of TAAA. Moreover, in a broader sense, this technique can be applied to any number of situations in which upper extremity arterial access is required for delivery of multiple sheaths or large sheaths. Although no prospective, direct comparisons exist to the brachial artery approach, it appears to be a safe and reliable option for most patients. 
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